Loading data
DCINYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Cost of revenue | 2.54 bn USD | 2.4 bn USD | 2.31 bn USD | 2.27 bn USD | 2.24 bn USD |
| Gross profit | 1.35 bn USD | 1.29 bn USD | 1.27 bn USD | 1.16 bn USD | 1.07 bn USD |
| Research and development expense | 76.1 m USD | 87.8 m USD | 93.6 m USD | 78.1 m USD | 69.1 m USD |
| Selling, general and administrative expense | 679.2 m USD | 642.2 m USD | 636.7 m USD | 602.3 m USD | 554.8 m USD |
| Operating profit | 599.9 m USD | 495.4 m USD | 544.1 m USD | 480.2 m USD | 443.5 m USD |
| Interest expense | — | — | — | 19.2 m USD | 14.9 m USD |
| Profit before tax | 585.8 m USD | 492.2 m USD | 535.3 m USD | 468.7 m USD | 438.4 m USD |
| Income tax expense | 132 m USD | 125.2 m USD | 121.3 m USD | 109.9 m USD | 105.6 m USD |
| Net income (reported basis) | 454 m USD | 367 m USD | 414 m USD | 359 m USD | 333 m USD |
| Basic earnings per share | 3.92 USD/share | 3.09 USD/share | 3.43 USD/share | 2.95 USD/share | 2.69 USD/share |
| Diluted earnings per share | 3.85 USD/share | 3.05 USD/share | 3.38 USD/share | 2.9 USD/share | 2.66 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.